Антибиотики и Химиотерапия (May 2020)

In vivo Efficacy of Ingavirin® Against Pandemic A(H1N1/09)v Influenza Virus

  • L. N. Shishkina,
  • V. E. Nebolsin,
  • M. O. Skarnovich,
  • A. S. Kabanov,
  • A. A. Sergeev,
  • U. B. Erdyneeva,
  • O. A. Serova,
  • O. K. Demina,
  • A. P. Agafonov,
  • E. A. Stavsky,
  • I. G. Drozdov

Journal volume & issue
Vol. 55, no. 5-6
pp. 32 – 35

Abstract

Read online

Ingavirin® was shown to be efficient in inhibition of the pandemic influenza virus strains A/California/04/2009 (H1N1)v, A/California/07/2009 (H1N1)v, A/Moscow/225/2009 (H1N1)v and A/Moscow/226/2009 (H1N1)v. as well as the influenza virus strain A/Aichi/2/68 (H3N2) in the lungs of the infected mice. After oral administration of Ingavirin® the titers of the influenza virus strains in the lung homogenates lowered.

Keywords